Business Context and Reporting Period
This Form 6-K filing by Gold Fields Limited (JSE, NYSE, DIFX: GFI) covers the month of November 2011. The report is a compliance disclosure regarding director dealings in securities, specifically the exercise of Share Appreciation Rights (SARS) by Director Mr. NJ Holland on November 14, 2011.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company. The only financial data presented relates to the specific director transaction:
- Transaction Date: November 14, 2011
- Market Price per Share: R137.1777
- Total Proceeds from Sale: R372,453.26 (Aggregated from four separate transactions)
- Total Value of SARS Exercised: R1,757,657.85
Material Changes
The filing does not report material changes to the Company's operations, financial condition, or results of operations compared to prior periods. It solely discloses a change in the Director's beneficial interest resulting from the exercise of equity incentives.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It confirms that necessary clearance to deal in the securities was obtained in compliance with JSE Listings Requirements.
Important Facts for Investors
- Director Activity: Director NJ Holland exercised SARS and sold the resulting shares on the open market.
- Transaction Volume: A total of 12,813 ordinary shares were sold across four distinct tranches.
- Strike Prices: The SARS were allocated at strike prices ranging from R103.99 to R125.28.
- Profit Realization: The Director realized proceeds of approximately R372,453 from the sale of shares acquired through the SARS scheme.
- Financial Data Limitation: This document does not contain the Company's quarterly or annual financial performance data.